TeselaGen Press Releases

TeselaGen Releases Alpha Version of Tesela Copilot: An AI Agent for Accelerating Life Science Innovation

May 19, 2025

TeselaGen, a leading provider of AI-augmented design and automation software for biotechnology, announced the recent alpha release of its powerful agentic Copilot, seamlessly integrated with TeselaGen’s Platform for Biological R&D. This breakthrough solution harnesses advanced artificial intelligence to streamline experiment planning, accelerate data analysis, and enhance bioproduct development for researchers in molecular biology, biochemistry, and life sciences in general.

Read More »

TeselaGen Announces Spin-Off, Built Biotechnologies, Aims to Advance DNA Manufacturing

December 14, 2023

TeselaGen Biotechnology, Inc., a leader in biological design and process automation, has announced the launch of its spin-off, Built Biotechnologies, Inc., to revolutionize DNA manufacturing. Specializing in advanced DNA workflows crucial for cell and gene therapies and other biotech sectors, Built addresses the challenge of constructing complex DNA molecules, essential for advancing synthetic biology.

Read More »

TeselaGen Receives Two New Patents for Using Artificial Intelligence to Accelerate Biotech Product Development

October 20, 2023

TeselaGen Biotechnology Inc. announces the acquisition of two cutting-edge patents that advance AI-driven optimization of biological phenotypes. These additions fortify the company’s intellectual property, emphasizing its dedication to revolutionizing the biotech industry. CEO Eduardo Abeliuk states that these patents mark a significant milestone for TeselaGen, highlighting the role of AI in streamlining biotech product development. The company’s collaborations with pioneering biotech firms underscore its commitment to innovation and industry advancement.

Read More »

TeselaGen Helps Early-Stage BioTech Startups Scale Faster and More Efficiently with Its Starter Edition

March 24, 2023

“TeselaGen has saved us countless hours throughout our DNA assembly design process and enabled us to perform high-throughput DNA library construction. In addition, their user interface is intuitive, and their customer support has been exceptional. We have been able to make it easy for us to train new team members and get them using the software productively,” added Kobe Rogers, COO of Ourobio.

Read More »

TeselaGen Secures Contract from BioMADE to Accelerate US Biomanufacturing with Advanced Informatics and Artificial Intelligence

February 11, 2022

TeselaGen Biotechnology announced today a two-year contract with BioMADE, the Department of Defense-sponsored bioindustrial Manufacturing Innovation Institute, to improve the informatics infrastructure around fermentation-based biomanufacturing. As part of this collaboration, TeselaGen will develop novel technologies that standardize data exchange, connect disparate software systems, and establish secure protocols to facilitate collaboration on AI-enabled projects.

Read More »

Subscribe

We're committed to your privacy. TeselaGen uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time.